We believe that by having a better understanding of genetic conditions, we will be able to develop better treatments. We have formed a team of experienced researchers and medical staff that is combining their experience and knowledge to uncover the causes of neurodevelopmental disorders and improve behavioral and medical treatment options.
Participating in ADMI studies allows our innovation & research centers to form a new outlook on the evaluation & treatment of children with special developmental needs.
Making Advances Possible (MAP) Protocol
The MAP Protocol is focused on collecting detailed information about health and development to better understand neurodevelopmental conditions. Participants may conduct additional speech, behavioral, developmental, and/or neurological tests outside of what they might do in a normal clinic visit.
Geisinger MyCode® Community Health Initiative
This Geisinger-wide study involves collecting blood, saliva (spit), and health information from thousands of Geisinger patients for use in future research studies. By studying the genes and up-to-date medical information of a patient, researchers will be able to better understand, treat, or prevent different medical conditions.
GenomeConnect Survey Validation
At Geisinger’s Autism & Developmental Medicine Institute (ADMI) we want to help make sure we are gathering the best information we can from parents, because parents are the experts about their children’s health history. To that end, we are conducting research in which we are asking parents to help us improve health survey questionnaires used by GenomeConnect, a patient registry. By participating in our study, you can help us to understand the difference between what YOU know about your child’s health and what’s actually in our records. This project is related to GenomeConnect, the Clinical Genome Resource patient portal.